Phototherapy

Home-based phototherapy proved effective for the treatment of plaque and guttate psoriasis across skin types, providing a convenient therapy method for patients, according to a study.

Otezla is now available in the U.S. for the treatment of moderate to severe plaque psoriasis in children and adolescents aged 6 years and older, Amgen announced in a press release.

The first 100 patients have been enrolled in a clinical trial investigating a novel light therapy device intended to treat individuals with Parkinson’s disease, according to the manufacturer.

SAN DIEGO — In patients with active nonsegmental vitiligo, ritlecitinib monotherapy or paired with twice weekly narrowband ultraviolet B phototherapy improved facial and total body repigmentation, according to a speaker here.

SAN DIEGO — In this video perspective, Healio Dermatology Chief Medical Editor Joel M. Gelfand, MD, MSCE, discusses highlights from the LITE study on home vs. office-based phototherapy for plaque or guttate psoriasis.

SAN DIEGO — In a real-world setting, treatment with home-based phototherapy was noninferior to office phototherapy for people with plaque or guttate psoriasis, with both options safe and efficacious, according to a speaker here.

Sequential fat grafting with fresh fat and cryopreserved stromal vascular fraction gel was safe and beneficial for patients with morphea, according to a study.

Patients with plaque or guttate psoriasis treated with at-home phototherapy experienced similar benefits to those treated in-office, according to topline study data.